Tagomics

Decoding disease using multiomics

Add To Watchlist
General Information
Company Name
Tagomics
Founded Year
2020
Location (Offices)
Founders / Decision Makers
Jack Kennefick - Co-founder, Director & CEO Rob Neely - Chief Scientific Officer & Founder
Number of Employees
19
Industries
Biotechnology, Life Sciences
Funding Stage
Seed
Social Media

Tagomics - Company Profile

Tagomics is a biotechnology startup founded in 2020 with the slogan "Decoding disease using multiomics." The company focuses on harnessing the power of multiomics to accelerate disease understanding and diagnosis. In its latest milestone, Tagomics secured a significant £6.70M Seed Round investment on 21 February 2024. The investment was led by a diverse group of notable investors, including Agilent Ventures, Illumina Ventures, IQ Capital, Calculus Capital, OMX Ventures, MEIF Proof-of-Concept & Early Stage Fund, Mercia Ventures, and Meltwind Advisory. This recent infusion of capital positions Tagomics for further growth and development in its mission to revolutionize disease decoding through multiomics.

Taxonomy: multiomics, disease understanding, diagnosis acceleration, multiomic profiling, disease decoding

Funding Rounds & Investors of Tagomics (1)

View All
Funding Stage Amount No. Investors Investors Date
Seed Round £6.70M 8
Agilent Ventures, investor in Tagomics's Seed Round round Illumina Ventures, investor in Tagomics's Seed Round round IQ Capital, investor in Tagomics's Seed Round round Calculus Capital, investor in Tagomics's Seed Round round OMX Ventures, investor in Tagomics's Seed Round round MEIF Proof-of-Concept & Early Stage Fund, investor in Tagomics's Seed Round round
Mercia Ventures, Meltwind Advisory 		21 Feb 2024

Latest News of Tagomics

View All

No recent news or press coverage available for Tagomics.

Similar Companies to Tagomics

View All
RespiQ - Similar company to Tagomics
RespiQ Smart breath testing for better health.
MitoRx Therapeutics - Similar company to Tagomics
MitoRx Therapeutics Our mission is to arrest the progression of degenerative diseases driven by mitochondrial dysfunction
T3D Therapeutics, Inc. - Similar company to Tagomics
T3D Therapeutics, Inc. Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegenerative diseases.
G3P - Similar company to Tagomics
G3P Galectin-3 in health and disease and the role of pectins
Avolynt, Inc. - Similar company to Tagomics
Avolynt, Inc.
Circle Decoration Circle Decoration

Want to dive deeper into Tagomics? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now